Article
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.
International journal of molecular sciences - 5 Mar 2021
Rebuzzi Sara Elena, Zullo Lodovica, Rossi Giovanni, Grassi Massimiliano, Murianni Veronica, Tagliamento Marco, Prelaj Arsela, Coco Simona, Longo Luca, Dal Bello Maria Giovanna, Alama Angela, Dellepiane Chiara, Bennicelli Elisa, Malapelle Umberto, Genova Carlo
Abstract excerpt
In the scenario of systemic treatment for advanced non-small cell lung cancer (NSCLC) patients, one of the most relevant breakthroughs is represented by targeted therapies. Throughout the last years, inhibitors of the epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), c-Ros oncogene 1 (ROS1), and V-raf murine sarcoma viral oncogene homolog B (BRAF) have been approved and are currently used...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.